Status:

COMPLETED

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers

Lead Sponsor:

Promentis Pharmaceuticals, Inc.

Collaborating Sponsors:

Celerion

Conditions:

Healthy

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This is a randomized, double-blind, placebo-controlled, single ascending oral dose and food effect study conducted at one study center in the United States. Safety and tolerability will be assessed th...

Eligibility Criteria

Inclusion

  • Healthy adult male or females (women of non child bearing potential), 18-55 years of age (inclusive).
  • Medically healthy with no clinically significant screening results.
  • Non-vasectomized male subjects must agree to use birth control or abstain from sexual intercourse during and until 90 days beyond the last dose of study drug/placebo.
  • Continuous non-smoker, at least 3 months prior to first dose and throughout the study.
  • Understands the study procedures in the informed consent form, and be willing and able to comply with the protocol

Exclusion

  • Subject is mentally or legally incapacitated.
  • History of any illness that, in the opinion of the PI, might confound the results of the study or poses an additional risk to the subjects by their participation in the study.
  • History or presence of alcoholism or drug abuse within the past 2 years
  • Female subject of childbearing potential.
  • Blood donation or significant blood loss within 56 days prior to first dose.
  • Plasma donation within 7 days prior to first dose.
  • Participation in another clinical trial within 30 days prior to first dose.

Key Trial Info

Start Date :

September 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 13 2018

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT03301298

Start Date

September 11 2017

End Date

February 13 2018

Last Update

September 26 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Celerion

Tempe, Arizona, United States, 85283